←Back to Expert Scholars
Translational Medicine / 转化医学FGFR Inhibitor Therapy
Andrea Varga
MD, PhD
🏢Gustave Roussy🌐France
Medical Oncologist
35
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Andrea Varga leads phase I trials at Gustave Roussy and has contributed to FGFR inhibitor development. Her work addresses early clinical evaluation of molecularly targeted agents. She participates in first in human studies of multiple drugs advancing to later stage trials. Her research supports European leadership in precision oncology.
Share:
🧪Research Fields 研究领域
phase I trials
FGFR inhibitors
targeted therapy
drug development
solid tumors
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Andrea Varga 的研究动态
Follow Andrea Varga's research updates
留下邮箱，当我们发布与 Andrea Varga（Gustave Roussy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment